Aehr Test Systems Form 4 insider transactions

NASDAQ
Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 5,000 shares of common stock at $90 per share.
NASDAQ
Director Rhea J. Posedel sold 8,787 shares of Aehr Test Systems common stock at an average price of $96.0233.
NASDAQ
Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 6,486 shares of common stock.
NASDAQ
Alistair N. Sporck, VP of Aehr Test Systems, reported the withholding of 341 shares to satisfy tax obligations upon the vesting of restricted stock units.
NASDAQ
Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 2,431 shares of common stock.
NASDAQ
Director Rhea J. Posedel sold 7,500 shares of Aehr Test Systems common stock on April 20, 2026.
NASDAQ
Director Fariba Danesh exercised options and immediately sold 8,000 shares of Aehr Test Systems at a significant premium.
NASDAQ
Director Rhea J. Posedel disposed of 7,500 shares of Aehr Test Systems common stock at a price of $82.00 per share.
NASDAQ
Aehr Test Systems Director Howard T. Slayen reported the sale of 25,000 shares of common stock at a price of $85 per share.
NASDAQ
Director Laura Oliphant sold 1,716 shares of Aehr Test Systems common stock on April 16, 2026.
NASDAQ
Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 5,000 shares of common stock on April 16, 2026.
NASDAQ
Alistair N. Sporck, VP of Aehr Test Systems, sold 2,000 shares of common stock on April 16, 2026.
NASDAQ
Director Laura Oliphant sold 4,665 shares of Aehr Test Systems common stock on April 16, 2026.
NASDAQ
Director Rhea J. Posedel sold 15,000 shares of Aehr Test Systems common stock on April 16, 2026.
NASDAQ
Director Geoffrey G. Scott filed an amendment to a previous Form 4 to correct transaction prices and share quantities for spouse-held Aehr Test Systems stock.
NASDAQ
Didier Wimmers, Executive VP of R&D at Aehr Test Systems, sold 5,400 shares of common stock in mid-April 2026.
NASDAQ
Donald P. Richmond II, CTO of Aehr Test Systems, sold 17,011 shares of common stock at an average price of $73.1764.
NASDAQ
Gayn Erickson, President and CEO of AEHR TEST SYSTEMS, reported a transaction involving common stock on April 14, 2026.
NASDAQ
AEHR TEST SYSTEMS CFO Chris Siu reported transactions involving company common stock, including shares withheld for tax obligations and holdings subject to unvested restricted stock units.
NASDAQ
Vernon Rogers, Exec VP of Sales & Mktg. at Aehr Test Systems, reported transactions involving common stock, including shares withheld for tax obligations.
NASDAQ
Donald P. Richmond II, CTO of Aehr Test Systems, reported transactions involving common stock, including shares withheld for tax obligations.
NASDAQ
Gayn Erickson, President and CEO of AEHR TEST SYSTEMS, reported transactions involving company stock on April 10-11, 2026.
NASDAQ
A Form 4 filing for Aehr Test Systems reports stock transactions by insider Alistair N. Sporck, including acquisitions and holdings.
NASDAQ
Adil Engineer, Chief Operating Officer of Aehr Test Systems, reported transactions involving the acquisition and disposition of company common stock.
NASDAQ
Fariba Danesh, a Director at AEHR TEST SYSTEMS, reported transactions involving the purchase and sale of company stock.
NASDAQ
Vernon Rogers, Exec VP of Sales & Mktg. at AEHR TEST SYSTEMS, reported a transaction involving 10,888 shares of common stock on April 10, 2026.
NASDAQ
Adil Engineer, Chief Operating Officer of Aehr Test Systems, reported transactions involving the acquisition and disposition of company stock.
NASDAQ
Donald P. Richmond II, CTO of Aehr Test Systems, reported a sale of 15,751 shares of common stock on April 9, 2026, for $68.6849 per share.
NASDAQ
Laura Oliphant, a Director at AEHR Test Systems, reported a transaction involving the acquisition of 3,000 shares of common stock.
NASDAQ
Rhea J. Posedel, a Director at AEHR Test Systems, has reported a transaction involving 30,000 shares of common stock.